Variation in size, shape and smell is normal. Your poop will change depending on what you've eaten and how much water you've had to drink. You'll experience different types over time; it only ...

Baby poop can vary greatly. However, a milk allergy or lactose intolerance may cause poop to be more watery and frequent than usual. Cow’s milk allergy is one of the most common food allergies ...

Something strange is happening inside hardware stores across the world, prompting health experts to weigh in on the bizarre phenomenon. Shoppers are reporting a sudden and unexplained urge to go ...

Noticing grey poop may come as a surprise, but it's not always an emergency. Grey poop occasionally happens when you take certain medications for long periods. More frequent grey-colored poop ...

An infant’s poop typically changes color and consistency during the first few days, weeks, and months of life. A wide range of colors is usual. In infants, the main reasons for changes in stool ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...